Could a spinal implant ease pain and boost recovery after paralysis?

NCT ID NCT04894734

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an implanted spinal cord stimulator can reduce chronic pain and improve rehabilitation outcomes in people with thoracic spinal cord injury. Twenty-five participants will either have the device turned on or off for three months, while both groups continue standard care like medication and physical therapy. After that, the placebo group can also receive stimulation. The goal is to see if the device is feasible and helpful for pain, movement, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

spinal cord stimulator (implanted device)

What this could lead to

If it works, this could point toward a way to reduce chronic pain and improve movement, bowel/bladder function, and quality of life after spinal cord injury.

What could go wrong

This is a very small, early feasibility study with only 25 people. It is not designed to prove effectiveness, and results may not apply to everyone. Surgery to implant the device carries risks like infection or device failure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY AT T1-T12 LEVEL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Duke University Health Systems

    Durham, North Carolina, 27710, United States